About: Structural changes in the bronchial mucosa of young children at risk of developing asthma     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : http://linked.opendata.cz/ontology/domain/vavai/Vysledek, within Data Space : linked.opendata.cz associated with source document(s)

AttributesValues
rdf:type
rdfs:seeAlso
Description
  • Background Allergen-specific immunotherapy (IT) is widely used to treat allergic diseases. The molecular mechanisms have not been clarified yet completely. The present work was undertaken to analyze the effect of IT in the activation of NF-kappa B. Methods Neutrophils from 15 pollen-allergic IT-treated patients, 10 untreated pollen-allergic patients, and 10 healthy donors were in vitro stimulated with LPS. NF-kappa B activation (p65/p52) was measured in their nuclear extracts by enzyme-linked immunosorbent assay (ELISA). I kappa B alpha phosphorylation, NF-kappa B-repressing factor (NRF) activation, and thromboxane A(2) (TXA(2)) and Interleukin-8 (IL-8) release were measured by ELISA. Results There was a positive correlation between the score of symptoms and NF-kappa B activation in human neutrophils. IT significantly decreased NF-kappa B activation levels in neutrophils compared with neutrophils from untreated patients. I kappa B alpha phosphorylation and NRF activation levels were, respectively, significantly lower and higher in neutrophils from IT-treated patients than from untreated patients. IL-8 and TXA(2) release were significantly lower in neutrophils from IT-treated patients than from untreated patients. Conclusions IT positive effects are at least in part mediated by the negative regulation of NF-kappa B activation in human neutrophils. These observations represent a novel view of neutrophils as possible cell target to treat IgE-dependent diseases through NF-kappa B downmodulation.
  • Background Allergen-specific immunotherapy (IT) is widely used to treat allergic diseases. The molecular mechanisms have not been clarified yet completely. The present work was undertaken to analyze the effect of IT in the activation of NF-kappa B. Methods Neutrophils from 15 pollen-allergic IT-treated patients, 10 untreated pollen-allergic patients, and 10 healthy donors were in vitro stimulated with LPS. NF-kappa B activation (p65/p52) was measured in their nuclear extracts by enzyme-linked immunosorbent assay (ELISA). I kappa B alpha phosphorylation, NF-kappa B-repressing factor (NRF) activation, and thromboxane A(2) (TXA(2)) and Interleukin-8 (IL-8) release were measured by ELISA. Results There was a positive correlation between the score of symptoms and NF-kappa B activation in human neutrophils. IT significantly decreased NF-kappa B activation levels in neutrophils compared with neutrophils from untreated patients. I kappa B alpha phosphorylation and NRF activation levels were, respectively, significantly lower and higher in neutrophils from IT-treated patients than from untreated patients. IL-8 and TXA(2) release were significantly lower in neutrophils from IT-treated patients than from untreated patients. Conclusions IT positive effects are at least in part mediated by the negative regulation of NF-kappa B activation in human neutrophils. These observations represent a novel view of neutrophils as possible cell target to treat IgE-dependent diseases through NF-kappa B downmodulation. (en)
Title
  • Structural changes in the bronchial mucosa of young children at risk of developing asthma
  • Structural changes in the bronchial mucosa of young children at risk of developing asthma (en)
skos:prefLabel
  • Structural changes in the bronchial mucosa of young children at risk of developing asthma
  • Structural changes in the bronchial mucosa of young children at risk of developing asthma (en)
skos:notation
  • RIV/00216208:11130/14:10293025!RIV15-MSM-11130___
http://linked.open...avai/riv/aktivita
http://linked.open...avai/riv/aktivity
  • I, S
http://linked.open...iv/cisloPeriodika
  • 2
http://linked.open...vai/riv/dodaniDat
http://linked.open...aciTvurceVysledku
http://linked.open.../riv/druhVysledku
http://linked.open...iv/duvernostUdaju
http://linked.open...titaPredkladatele
http://linked.open...dnocenehoVysledku
  • 47843
http://linked.open...ai/riv/idVysledku
  • RIV/00216208:11130/14:10293025
http://linked.open...riv/jazykVysledku
http://linked.open.../riv/klicovaSlova
  • allergen immunotherapy; asthma; neutrophils; NF-kappa B (en)
http://linked.open.../riv/klicoveSlovo
http://linked.open...odStatuVydavatele
  • DK - Dánské království
http://linked.open...ontrolniKodProRIV
  • [03936420EF61]
http://linked.open...i/riv/nazevZdroje
  • Pediatric Allergy and Immunology
http://linked.open...in/vavai/riv/obor
http://linked.open...ichTvurcuVysledku
http://linked.open...cetTvurcuVysledku
http://linked.open...UplatneniVysledku
http://linked.open...v/svazekPeriodika
  • 25
http://linked.open...iv/tvurceVysledku
  • Pohunek, Petr
  • Uhlík, Jiří
  • Beránková, Katarína
  • Hoňková, Lenka
http://linked.open...ain/vavai/riv/wos
  • 000332968000005
issn
  • 0905-6157
number of pages
http://bibframe.org/vocab/doi
  • 10.1111/pai.12119
http://localhost/t...ganizacniJednotka
  • 11130
Faceted Search & Find service v1.16.118 as of Jun 21 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 44 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software